Cytokine profile in autistic patients

Area of Science:

• Neuroimmunology
• Developmental Neuroscience
• Genetics

Background:

• The exact causes of Autism Spectrum Disorders (ASDs), a group of severe neurodevelopmental conditions, remain unknown.
• Emerging evidence suggests that immune system dysregulation may play a significant role in the pathophysiology of ASD.

Purpose of the Study:

• To investigate the mRNA expression levels of key immune-related cytokines in individuals with ASD.
• To determine if specific cytokine expression patterns are associated with ASD.

Main Methods:

• Real-time quantitative polymerase chain reaction (qPCR) was used to measure the mRNA expression of ten cytokines (TNF-α, TGF-β, IFN-γ, CXCL8, IL-1β, IL-2, IL-4, IL-6, IL-17) in whole blood samples.
• The study included 30 patients diagnosed with ASD and 41 age- and sex-matched healthy control subjects.

Main Results:

• Significant upregulation of Tumor Necrosis Factor-alpha (TNF-α), Interleukin-6 (IL-6), and Interleukin-17 (IL-17) was observed in ASD patients compared to healthy controls (P < 0.0001, P = 0.001, P < 0.0001, respectively).
• A significant downregulation of Interleukin-2 (IL-2) was found in the ASD group (P < 0.0001).
• No significant differences in the expression levels of other tested cytokines were detected between the groups.

Conclusions:

• The findings provide further evidence supporting the hypothesis of immune system dysregulation in individuals with ASD.
• Altered expression of specific cytokines like TNF-α, IL-6, IL-17, and IL-2 may be implicated in the immune mechanisms underlying ASD.